ADC Therapeutics reported cash from operations of -$11.81M and free cash flow of -$11.81M for the quarter ended Jun 2026, up 51.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -71.55M | -16.66M | -64.37M | -50.61M | -59.43M | -48.20M | -45.30M | -46.00M | -35.95M | -43.71M | -38.60M | -56.65M | -40.97M | -32.97M | -16.57M | |||||||||||
| Share-based CompensationStock Comp. | 14.80M | 13.46M | 13.40M | 13.82M | 14.56M | 7.54M | 8.07M | 1.12M | 2.08M | 2.22M | 0.16M | 1.99M | 2.81M | 1.62M | 2.42M | 1.81M | 2.00M | 0.67M | 2.44M | 4.55M | ||||||
| Deferred Taxes | -0.07M | -5.10M | -0.58M | 42.85M | ||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | -0.62M | -0.02M | -0.14M | 0.28M | 3.07M | 2.23M | -1.13M | -0.00M | -2.23M | -14.40M | ||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.05M | 0.73M | 0.83M | 0.75M | 0.29M | 0.48M | 1.25M | 0.39M | 0.24M | 0.41M | 1.47M | 0.17M | ||||||||||||||
| Cash from OperationsCash from Ops. | -58.59M | -61.63M | -33.88M | -53.01M | 2.19M | -53.61M | -15.39M | -34.99M | -36.67M | -31.63M | -44.09M | -32.84M | -25.04M | -21.85M | -56.33M | -24.09M | -29.63M | -31.12M | -29.71M | -11.81M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.46M | 0.54M | 0.57M | 0.51M | 0.51M | 0.51M | 0.47M | 0.45M | 0.46M | 0.48M | 0.12M | 0.11M | 0.11M | |||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.50M | 0.44M | 0.52M | -0.56M | 0.19M | 0.65M | 0.73M | 0.25M | 0.23M | 0.94M | ||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -13.82M | -14.32M | 3.47M | 5.89M | -2.42M | 35.82M | -48.90M | -0.19M | -2.70M | 4.00M | -2.00M | -0.32M | 1.26M | -3.71M | 11.45M | -5.58M | -3.27M | 6.19M | 1.93M | -3.01M | ||||||
| Change in InventoryChange Inventory | 0.35M | 2.05M | 3.48M | -0.17M | 0.57M | -0.52M | 0.88M | 2.80M | 0.31M | 0.71M | 0.52M | 0.85M | -0.02M | 3.29M | ||||||||||||
| Change in Account PayablesChange Payables | -3.93M | 1.74M | 4.38M | -3.41M | -1.38M | 0.72M | -3.66M | 2.98M | -2.71M | 6.57M | -1.25M | -4.84M | 4.87M | 3.68M | -2.46M | -6.22M | -1.29M | 0.93M | -3.87M | 7.47M | ||||||
| Change in Accured ExpensesChange Accured Exp. | -12.30M | -3.29M | -0.52M | 1.96M | -3.54M | -2.19M | 5.57M | 11.30M | -20.63M | 12.04M | -0.80M | 1.97M | -3.18M | 3.82M | ||||||||||||
| Change in TaxesChange Taxes | 0.06M | 0.08M | ||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | -0.64M | -4.29M | -1.31M | -1.04M | 0.42M | 0.44M | 1.20M | -0.57M | ||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1.41M | 0.42M | 0.23M | 0.05M | 0.19M | 0.21M | 1.02M | 1.21M | 0.66M | 0.33M | 0.53M | 0.03M | 0.22M | 0.09M | 0.26M | 0.03M | ||||||||||
| Cash from Investing ActivitiesCash from Investing | -2.34M | -0.83M | -1.45M | -0.69M | -0.25M | 1.70M | -1.02M | -1.21M | -0.66M | -0.33M | -0.53M | -0.03M | -0.22M | -0.09M | -0.26M | 0.66M | -0.03M | |||||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.42M | 0.35M | -0.00M | 0.32M | 36.60M | 0.27M | 50.49M | 14.61M | 0.20M | 0.12M | ||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 219.30M | -1.22M | -0.26M | -0.25M | 2.37M | -2.75M | 0.42M | 73.10M | 0.35M | -0.00M | 0.36M | 98.70M | -0.88M | -1.12M | 0.27M | 93.78M | -0.20M | 57.09M | -0.58M | -0.10M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -1.23M | 43.24M | 43.52M | -0.02M | ||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.07M | 0.03M | -0.08M | -0.14M | -0.22M | 0.24M | 0.09M | 0.06M | -0.12M | 0.15M | -0.04M | 0.01M | 0.29M | -0.34M | 0.16M | 0.16M | 0.01M | -0.03M | -0.01M | 0.01M | ||||||
| Change in Cash | -15.98M | 36.90M | -36.98M | -31.96M | -44.27M | 65.82M | -26.14M | -23.06M | -56.33M | 69.70M | -29.83M | 26.62M | -30.32M | -11.91M | ||||||||||||
| Free Cash FlowFCF | -59.99M | -62.05M | -34.11M | -53.06M | 2.00M | -53.83M | -16.41M | -36.20M | -37.33M | -31.96M | -44.63M | -32.88M | -25.26M | -21.94M | -56.60M | -24.09M | -29.63M | -31.12M | -29.74M | -11.81M | ||||||
| Net Cash FlowNCF | 158.38M | -63.68M | -35.59M | -53.95M | 4.31M | -54.66M | -15.98M | 36.90M | -36.98M | -31.96M | -44.27M | 65.82M | -26.14M | -23.06M | -56.33M | 69.70M | -29.83M | 26.62M | -30.32M | -11.91M |